NOVADAQ Announces Definitive Agreement to Acquire Aimago SA
Marketwire - Thu Apr 24, 6:04AM CDT
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company"
NOVADAQ to Release First Quarter 2014 Financial Results on May 7, 2014-Conference Call to Follow
Marketwire - Wed Apr 23, 6:02AM CDT
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company"
TauTona Group Sells Aline HA(R) to Allergan
Marketwire - Thu Apr 17, 7:30AM CDT
TauTona Group, a medical device incubator and investment fund focused on the rapid development of innovative medical products, today announced that its wholly-owned subsidiary Aline Aesthetics has completed the sale of its Aline hyaluronic acid (HA) thread technology to Allergan, Inc. The Aline HA technology is under development for use as a dermal filler.
Equities to Watch in the Health Care Sector -- Research on Novadaq Technologies, Quest Diagnostics, Cooper Cos, and AcelRx Pharma
PR Newswire - Tue Apr 15, 11:56AM CDT
The trading session on Monday, April 14, 2014 ended on a higher note as the Dow Jones Industrial Average finished at 16,173.24, up 0.91% and the NASDAQ Composite closed at 4,022.69, up 0.57%. The S&P 500 finished the session 0.82% higher at 1,830.61. The gains were broad based as all the ten sectors finished on a positive note. The S&P 500 Health Care Sector Index finished the day at 648.05, up 0.51%, while the same has declined 3.97% in the last one month. Investor-Edge has initiated coverage on the following equities: Novadaq Technologies Inc. (NASDAQ: NVDQ), Quest Diagnostics Inc. (NYSE: DGX), The Cooper Cos Inc. (NYSE: COO) and AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX). Free technical research on NVDQ, DGX, COO and ACRX can be downloaded upon signing up at:
Nasdaq stocks posting largest percentage decreases
AP - Mon Apr 07, 12:50PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
Why Novadaq Tecnologies (NVDQ) Stock Hit an All-Time High, Then Plunged Today
at The Street - Fri Apr 04, 1:21PM CDT
Novadaq Technologies (NVDQ) hit an all-time high of $24.09 on Friday after Canaccord increased its target price to $26 from $23. The firm called Novadaq "the most compelling growth story in med-tech." But just before noon, the stock turned downward...
Clinical Trial Initiation, Executive Appointments, Priced Offering, FDA Clearance, and Upcoming Conferences - Analyst Notes on Cytokinetics, Quintiles, Kindred, Volcano, and Novadaq
PR Newswire - Tue Apr 01, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Cytokinetics, Inc. (NASDAQ: CYTK), Quintiles Transnational Holdings, Inc. (NYSE: Q), Kindred Healthcare, Inc. (NYSE: KND), Volcano Corporation (NASDAQ: VOLC), and Novadaq Technologies Inc. (NASDAQ: NVDQ). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
NOVADAQ to Present at the 13th Annual Needham Healthcare Conference
Marketwire - Tue Mar 25, 6:02AM CDT
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company"
Is This the Top for Novadaq (NVDQ)? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 17, 6:29AM CDT
Is This the Top for Novadaq (NVDQ)?
Novadaq to Present at March Investor Healthcare Meetings
Marketwire - Mon Mar 03, 6:02AM CST
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company"
NOVADAQ to Present at the 2014 RBC Capital Markets Healthcare Conference
Marketwire - Tue Feb 11, 6:01AM CST
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company"
NOVADAQ Reports 2013 Fourth Quarter and Full Year Financial Results
Marketwire - Thu Feb 06, 6:01AM CST
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company"